ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
Publicacións (468) Publicacións de ANDRES MANUEL R CERVANTES RUIPEREZ
2024
-
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Nature Medicine, Vol. 30, Núm. 1, pp. 271-278
-
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)
European Journal of Cancer, Vol. 204
-
Generation, Expansion, and Biobanking of Gastrointestinal Patient-Derived Organoids from Tumor and Normal Tissues
Methods in molecular biology (Clifton, N.J.), Vol. 2777, pp. 123-133
-
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer
ESMO Open, Vol. 9, Núm. 2
-
Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103)
Journal of Clinical Pharmacology, Vol. 64, Núm. 5, pp. 544-554
-
Regorafenib in patients with metastatic colorectal cancer in Spain: from clinical trials to real-world evidence
Future Oncology
-
The role of anti-EGFR rechallenge in metastatic colorectal cancer, from available data to future developments: A systematic review
Cancer Treatment Reviews, Vol. 124
-
Updated treatment recommendation for third-line treatment in advanced colorectal cancer from the ESMO Metastatic Colorectal Cancer Living Guideline
Annals of oncology : official journal of the European Society for Medical Oncology
-
ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients
Translational Research, Vol. 271, pp. 105-115
2023
-
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction"
Journal of experimental & clinical cancer research : CR, Vol. 42, Núm. 1, pp. 8
-
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial
JAMA oncology
-
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe
European Journal of Cancer, Vol. 185, pp. 28-39
-
Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results
Cancer Medicine, Vol. 12, Núm. 12, pp. 13145-13154
-
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
The Lancet Oncology, Vol. 24, Núm. 8, pp. 925-935
-
European expert panel consensus on the clinical management of BRAFV600E-mutant metastatic colorectal cancer
Cancer Treatment Reviews, Vol. 115
-
FOLFOXIRI plus bevacizumab as standard of care for first-line treatment in patients with advanced colon cancer
ESMO Open
-
How organoids can improve personalized treatment in patients with gastro-esophageal tumors
Current Opinion in Pharmacology, Vol. 69
-
In the Literature: January 2023
ESMO Open
-
In the Literature: March 2023
ESMO Open
-
In the literature: July 2023
ESMO Open